Millions of people around the world have Alzheimer’s disease, a form of dementia affecting memory and cognition.
With currently no cure for this condition, researchers estimate the number of people globally who have Alzheimer’s will almost double every 20 years.
For this reason, scientists have been placing a great deal of focus on finding new treatment options for Alzheimer’s disease.
Adding to this research is a new study by scientists at the University of Kentucky College of Medicine, who have found that a drug used to treat multiple sclerosis (MS) could also be used as a therapy for Alzheimer’s disease.
